Kerr JF (October 1965). “A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes”. The Journal of Pathology and Bacteriology90 (2): 419–435. doi:10.1002/path.1700900210. PMID5849603.
Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (August 2003). “Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin”. The Journal of Biological Chemistry278 (34): 31861–31870. doi:10.1074/jbc.m300190200. PMID12805375.
Uğuz AC, Naziroğlu M, Espino J, Bejarano I, González D, Rodríguez AB, Pariente JA (December 2009). “Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities”. The Journal of Membrane Biology232 (1–3): 15–23. doi:10.1007/s00232-009-9212-2. PMID19898892.
Chiarugi A, Moskowitz MA (July 2002). “Cell biology. PARP-1--a perpetrator of apoptotic cell death?”. Science297 (5579): 200–201. doi:10.1126/science.1074592. PMID12114611.
Gonzalez D, Bejarano I, Barriga C, Rodriguez AB, Pariente JA (2010). “Oxidative Stress-Induced Caspases are Regulated in Human Myeloid HL-60 Cells by Calcium Signal”. Current Signal Transduction Therapy5 (2): 181–186. doi:10.2174/157436210791112172.
Brüne B (August 2003). “Nitric oxide: NO apoptosis or turning it ON?”. Cell Death and Differentiation10 (8): 864–869. doi:10.1038/sj.cdd.4401261. PMID12867993.
Brüne B, von Knethen A, Sandau KB (October 1999). “Nitric oxide (NO): an effector of apoptosis”. Cell Death and Differentiation6 (10): 969–975. doi:10.1038/sj.cdd.4400582. PMID10556974.
Gerl R, Vaux DL (February 2005). “Apoptosis in the development and treatment of cancer”. Carcinogenesis26 (2): 263–270. doi:10.1093/carcin/bgh283. PMID15375012.
Masum AA, Yokoi K, Hisamatsu Y, Naito K, Shashni B, Aoki S (September 2018). “Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis”. Bioorganic & Medicinal Chemistry26 (17): 4804–4816. doi:10.1016/j.bmc.2018.08.016. PMID30177492.
Venturi S (2011). “Evolutionary Significance of Iodine”. Current Chemical Biology5 (3): 155–62. doi:10.2174/187231311796765012.
Tamura K, Takayama S, Ishii T, Mawaribuchi S, Takamatsu N, Ito M (June 2015). “Apoptosis and differentiation of Xenopus tail-derived myoblasts by thyroid hormone”. Journal of Molecular Endocrinology54 (3): 185–192. doi:10.1530/JME-14-0327. PMID25791374.
Razaghi A, Heimann K, Schaeffer PM, Gibson SB (February 2018). “Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies”. Apoptosis23 (2): 93–112. doi:10.1007/s10495-018-1440-4. PMID29322476.
Böhm I (May 2003). “Disruption of the cytoskeleton after apoptosis induction with autoantibodies”. Autoimmunity36 (3): 183–189. doi:10.1080/0891693031000105617. PMID12911286.
Zgorzelska, A (31 October 2025). “Changes of nanoviscosity during TRAIL-induced apoptosis of HeLa cells”. Cell Reports Physical Sciences. doi:10.1016/j.xcrp.2025.102927.
Kihlmark M, Imreh G, Hallberg E (October 2001). “Sequential degradation of proteins from the nuclear envelope during apoptosis”. Journal of Cell Science114 (Pt 20): 3643–3653. doi:10.1242/jcs.114.20.3643. PMID11707516.
Gong J, Traganos F, Darzynkiewicz Z (May 1994). “A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry”. Analytical Biochemistry218 (2): 314–319. doi:10.1006/abio.1994.1184. PMID8074286.
Iwata M, Myerson D, Torok-Storb B, Zager RA (December 1994). “An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury”. Journal of the American Society of Nephrology5 (6): 1307–1313. doi:10.1681/ASN.V561307. PMID7893995.
Smith A, Parkes MA, Atkin-Smith GK, Tixeira R, Poon IK (2017). “Cell disassembly during apoptosis” (英語). WikiJournal of Medicine4 (1). doi:10.15347/wjm/2017.008.
Tixeira R, Caruso S, Paone S, Baxter AA, Atkin-Smith GK, Hulett MD, Poon IK (March 2017). “Defining the morphologic features and products of cell disassembly during apoptosis”. Apoptosis22 (3): 475–477. doi:10.1007/s10495-017-1345-7. PMID28102458.
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF (April 2001). “Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I”. Nature Cell Biology3 (4): 339–345. doi:10.1038/35070009. PMID11283606.
Sebbagh M, Renvoizé C, Hamelin J, Riché N, Bertoglio J, Bréard J (April 2001). “Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing”. Nature Cell Biology3 (4): 346–352. doi:10.1038/35070019. PMID11283607.
Vandivier RW, Henson PM, Douglas IS (June 2006). “Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease”. Chest129 (6): 1673–1682. doi:10.1378/chest.129.6.1673. PMID16778289.
Halicka HD, Bedner E, Darzynkiewicz Z (November 2000). “Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis”. Experimental Cell Research260 (2): 248–256. doi:10.1006/excr.2000.5027. PMID11035919.
Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z (2011). “Apoptosis and beyond: cytometry in studies of programmed cell death”. Recent Advances in Cytometry, Part B – Advances in Applications. Methods in Cell Biology. 103. pp. 55–98. doi:10.1016/B978-0-12-385493-3.00004-8. ISBN978-0-12-385493-3. PMC3263828. PMID21722800
Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (July 2003). “Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence”. Nature424 (6948): 516–523. Bibcode: 2003Natur.424..516T. doi:10.1038/nature01850. PMID12872134.
Bernstein C, Bernstein H, Payne CM, Garewal H (June 2002). “DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis”. Mutation Research511 (2): 145–178. Bibcode: 2002MRRMR.511..145B. doi:10.1016/S1383-5742(02)00009-1. PMID12052432.
Liu HC, Chen GG, Vlantis AC, Tse GM, Chan AT, van Hasselt CA (March 2008). “Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16”. Journal of Cellular Biochemistry103 (4): 1125–1143. doi:10.1002/jcb.21490. PMID17668439.
Niu XY, Peng ZL, Duan WQ, Wang H, Wang P (2006). “Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo”. International Journal of Gynecological Cancer16 (2): 743–751. doi:10.1111/j.1525-1438.2006.00384.x. PMID16681755.
Liu Y, McKalip A, Herman B (May 2000). “Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation”. Journal of Cellular Biochemistry78 (2): 334–349. doi:10.1002/(sici)1097-4644(20000801)78:2<334::aid-jcb15>3.3.co;2-6. PMID10842327.
Boehm I (June 2006). “Apoptosis in physiological and pathological skin: implications for therapy”. Current Molecular Medicine6 (4): 375–394. doi:10.2174/156652406777435390. PMID16900661.
LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (January 1995). “The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice”. Nature Genetics9 (1): 21–30. doi:10.1038/ng0195-21. PMID7704018.
Mochizuki H, Goto K, Mori H, Mizuno Y (May 1996). “Histochemical detection of apoptosis in Parkinson's disease”. Journal of the Neurological Sciences137 (2): 120–123. doi:10.1016/0022-510X(95)00336-Z. PMID8782165.
Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, Palmer K, Russo A (July 2013). “Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study”. Neurology81 (4): 322–328. doi:10.1212/WNL.0b013e31829c5ec1. PMID23843468.
Farhana L, Dawson MI, Fontana JA (June 2005). “Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation”. Cancer Research65 (11): 4909–4917. doi:10.1158/0008-5472.CAN-04-4124. PMID15930313.
Alimonti JB, Ball TB, Fowke KR (July 2003). “Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS”. The Journal of General Virology84 (Pt 7): 1649–1661. doi:10.1099/vir.0.19110-0. PMID12810858.
Vashistha H, Husain M, Kumar D, Yadav A, Arora S, Singhal PC (2008). “HIV-1 expression induces tubular cell G2/M arrest and apoptosis”. Renal Failure30 (6): 655–664. doi:10.1080/08860220802134672. PMID18661417.
Everett H, McFadden G (April 1999). “Apoptosis: an innate immune response to virus infection”. Trends in Microbiology7 (4): 160–165. doi:10.1016/S0966-842X(99)01487-0. PMID10217831.
Nishi T, Tsukiyama-Kohara K, Togashi K, Kohriyama N, Kai C (November 2004). “Involvement of apoptosis in syncytial cell death induced by canine distemper virus”. Comparative Immunology, Microbiology and Infectious Diseases27 (6): 445–455. doi:10.1016/j.cimid.2004.01.007. PMID15325517.
Acrani GO, Gomes R, Proença-Módena JL, da Silva AF, Carminati PO, Silva ML, Santos RI, Arruda E (April 2010). “Apoptosis induced by Oropouche virus infection in HeLa cells is dependent on virus protein expression”. Virus Research149 (1): 56–63. doi:10.1016/j.virusres.2009.12.013. PMID20080135.
Indran IR, Tufo G, Pervaiz S, Brenner C (June 2011). “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells”. Biochimica et Biophysica Acta (BBA) - Bioenergetics1807 (6): 735–745. doi:10.1016/j.bbabio.2011.03.010. PMID21453675.
Polster BM, Pevsner J, Hardwick JM (March 2004). “Viral Bcl-2 homologs and their role in virus replication and associated diseases”. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research1644 (2–3): 211–227. doi:10.1016/j.bbamcr.2003.11.001. PMID14996505.
Hay S, Kannourakis G (July 2002). “A time to kill: viral manipulation of the cell death program”. The Journal of General Virology83 (Pt 7): 1547–1564. doi:10.1099/0022-1317-83-7-1547. PMID12075073.
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (February 1999). “Molecular characterization of mitochondrial apoptosis-inducing factor”. Nature397 (6718): 441–446. Bibcode: 1999Natur.397..441S. doi:10.1038/17135. PMID9989411.
Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (July 2003). “Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence”. Nature424 (6948): 516–523. Bibcode: 2003Natur.424..516T. doi:10.1038/nature01850. PMID12872134.
Bernstein C, Bernstein H, Payne CM, Garewal H (June 2002). “DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis”. Mutation Research511 (2): 145–178. Bibcode: 2002MRRMR.511..145B. doi:10.1016/S1383-5742(02)00009-1. PMID12052432.
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (February 1999). “Molecular characterization of mitochondrial apoptosis-inducing factor”. Nature397 (6718): 441–446. Bibcode: 1999Natur.397..441S. doi:10.1038/17135. PMID9989411.
Kerr JF (October 1965). “A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes”. The Journal of Pathology and Bacteriology90 (2): 419–435. doi:10.1002/path.1700900210. PMID5849603.
Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (August 2003). “Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin”. The Journal of Biological Chemistry278 (34): 31861–31870. doi:10.1074/jbc.m300190200. PMID12805375.
Uğuz AC, Naziroğlu M, Espino J, Bejarano I, González D, Rodríguez AB, Pariente JA (December 2009). “Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities”. The Journal of Membrane Biology232 (1–3): 15–23. doi:10.1007/s00232-009-9212-2. PMID19898892.
Chiarugi A, Moskowitz MA (July 2002). “Cell biology. PARP-1--a perpetrator of apoptotic cell death?”. Science297 (5579): 200–201. doi:10.1126/science.1074592. PMID12114611.
Brüne B (August 2003). “Nitric oxide: NO apoptosis or turning it ON?”. Cell Death and Differentiation10 (8): 864–869. doi:10.1038/sj.cdd.4401261. PMID12867993.
Brüne B, von Knethen A, Sandau KB (October 1999). “Nitric oxide (NO): an effector of apoptosis”. Cell Death and Differentiation6 (10): 969–975. doi:10.1038/sj.cdd.4400582. PMID10556974.
Gerl R, Vaux DL (February 2005). “Apoptosis in the development and treatment of cancer”. Carcinogenesis26 (2): 263–270. doi:10.1093/carcin/bgh283. PMID15375012.
Masum AA, Yokoi K, Hisamatsu Y, Naito K, Shashni B, Aoki S (September 2018). “Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis”. Bioorganic & Medicinal Chemistry26 (17): 4804–4816. doi:10.1016/j.bmc.2018.08.016. PMID30177492.
Tamura K, Takayama S, Ishii T, Mawaribuchi S, Takamatsu N, Ito M (June 2015). “Apoptosis and differentiation of Xenopus tail-derived myoblasts by thyroid hormone”. Journal of Molecular Endocrinology54 (3): 185–192. doi:10.1530/JME-14-0327. PMID25791374.
Razaghi A, Heimann K, Schaeffer PM, Gibson SB (February 2018). “Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies”. Apoptosis23 (2): 93–112. doi:10.1007/s10495-018-1440-4. PMID29322476.
Böhm I (May 2003). “Disruption of the cytoskeleton after apoptosis induction with autoantibodies”. Autoimmunity36 (3): 183–189. doi:10.1080/0891693031000105617. PMID12911286.
Kihlmark M, Imreh G, Hallberg E (October 2001). “Sequential degradation of proteins from the nuclear envelope during apoptosis”. Journal of Cell Science114 (Pt 20): 3643–3653. doi:10.1242/jcs.114.20.3643. PMID11707516.
Gong J, Traganos F, Darzynkiewicz Z (May 1994). “A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry”. Analytical Biochemistry218 (2): 314–319. doi:10.1006/abio.1994.1184. PMID8074286.
Iwata M, Myerson D, Torok-Storb B, Zager RA (December 1994). “An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury”. Journal of the American Society of Nephrology5 (6): 1307–1313. doi:10.1681/ASN.V561307. PMID7893995.
Tixeira R, Caruso S, Paone S, Baxter AA, Atkin-Smith GK, Hulett MD, Poon IK (March 2017). “Defining the morphologic features and products of cell disassembly during apoptosis”. Apoptosis22 (3): 475–477. doi:10.1007/s10495-017-1345-7. PMID28102458.
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF (April 2001). “Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I”. Nature Cell Biology3 (4): 339–345. doi:10.1038/35070009. PMID11283606.
Sebbagh M, Renvoizé C, Hamelin J, Riché N, Bertoglio J, Bréard J (April 2001). “Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing”. Nature Cell Biology3 (4): 346–352. doi:10.1038/35070019. PMID11283607.
Vandivier RW, Henson PM, Douglas IS (June 2006). “Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease”. Chest129 (6): 1673–1682. doi:10.1378/chest.129.6.1673. PMID16778289.
Halicka HD, Bedner E, Darzynkiewicz Z (November 2000). “Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis”. Experimental Cell Research260 (2): 248–256. doi:10.1006/excr.2000.5027. PMID11035919.
Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z (2011). “Apoptosis and beyond: cytometry in studies of programmed cell death”. Recent Advances in Cytometry, Part B – Advances in Applications. Methods in Cell Biology. 103. pp. 55–98. doi:10.1016/B978-0-12-385493-3.00004-8. ISBN978-0-12-385493-3. PMC3263828. PMID21722800
Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (July 2003). “Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence”. Nature424 (6948): 516–523. Bibcode: 2003Natur.424..516T. doi:10.1038/nature01850. PMID12872134.
Bernstein C, Bernstein H, Payne CM, Garewal H (June 2002). “DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis”. Mutation Research511 (2): 145–178. Bibcode: 2002MRRMR.511..145B. doi:10.1016/S1383-5742(02)00009-1. PMID12052432.
Liu HC, Chen GG, Vlantis AC, Tse GM, Chan AT, van Hasselt CA (March 2008). “Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16”. Journal of Cellular Biochemistry103 (4): 1125–1143. doi:10.1002/jcb.21490. PMID17668439.
Niu XY, Peng ZL, Duan WQ, Wang H, Wang P (2006). “Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo”. International Journal of Gynecological Cancer16 (2): 743–751. doi:10.1111/j.1525-1438.2006.00384.x. PMID16681755.
Liu Y, McKalip A, Herman B (May 2000). “Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation”. Journal of Cellular Biochemistry78 (2): 334–349. doi:10.1002/(sici)1097-4644(20000801)78:2<334::aid-jcb15>3.3.co;2-6. PMID10842327.
Boehm I (June 2006). “Apoptosis in physiological and pathological skin: implications for therapy”. Current Molecular Medicine6 (4): 375–394. doi:10.2174/156652406777435390. PMID16900661.
LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (January 1995). “The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice”. Nature Genetics9 (1): 21–30. doi:10.1038/ng0195-21. PMID7704018.
Mochizuki H, Goto K, Mori H, Mizuno Y (May 1996). “Histochemical detection of apoptosis in Parkinson's disease”. Journal of the Neurological Sciences137 (2): 120–123. doi:10.1016/0022-510X(95)00336-Z. PMID8782165.
Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, Palmer K, Russo A (July 2013). “Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study”. Neurology81 (4): 322–328. doi:10.1212/WNL.0b013e31829c5ec1. PMID23843468.
Farhana L, Dawson MI, Fontana JA (June 2005). “Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation”. Cancer Research65 (11): 4909–4917. doi:10.1158/0008-5472.CAN-04-4124. PMID15930313.
Alimonti JB, Ball TB, Fowke KR (July 2003). “Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS”. The Journal of General Virology84 (Pt 7): 1649–1661. doi:10.1099/vir.0.19110-0. PMID12810858.
Vashistha H, Husain M, Kumar D, Yadav A, Arora S, Singhal PC (2008). “HIV-1 expression induces tubular cell G2/M arrest and apoptosis”. Renal Failure30 (6): 655–664. doi:10.1080/08860220802134672. PMID18661417.
Everett H, McFadden G (April 1999). “Apoptosis: an innate immune response to virus infection”. Trends in Microbiology7 (4): 160–165. doi:10.1016/S0966-842X(99)01487-0. PMID10217831.
Nishi T, Tsukiyama-Kohara K, Togashi K, Kohriyama N, Kai C (November 2004). “Involvement of apoptosis in syncytial cell death induced by canine distemper virus”. Comparative Immunology, Microbiology and Infectious Diseases27 (6): 445–455. doi:10.1016/j.cimid.2004.01.007. PMID15325517.
Acrani GO, Gomes R, Proença-Módena JL, da Silva AF, Carminati PO, Silva ML, Santos RI, Arruda E (April 2010). “Apoptosis induced by Oropouche virus infection in HeLa cells is dependent on virus protein expression”. Virus Research149 (1): 56–63. doi:10.1016/j.virusres.2009.12.013. PMID20080135.
Indran IR, Tufo G, Pervaiz S, Brenner C (June 2011). “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells”. Biochimica et Biophysica Acta (BBA) - Bioenergetics1807 (6): 735–745. doi:10.1016/j.bbabio.2011.03.010. PMID21453675.
Polster BM, Pevsner J, Hardwick JM (March 2004). “Viral Bcl-2 homologs and their role in virus replication and associated diseases”. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research1644 (2–3): 211–227. doi:10.1016/j.bbamcr.2003.11.001. PMID14996505.
Hay S, Kannourakis G (July 2002). “A time to kill: viral manipulation of the cell death program”. The Journal of General Virology83 (Pt 7): 1547–1564. doi:10.1099/0022-1317-83-7-1547. PMID12075073.
Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC (December 1995). “Abrogation of p53-induced apoptosis by the hepatitis B virus X gene”. Cancer Research55 (24): 6012–6016. PMID8521383.
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (February 1999). “Molecular characterization of mitochondrial apoptosis-inducing factor”. Nature397 (6718): 441–446. Bibcode: 1999Natur.397..441S. doi:10.1038/17135. PMID9989411.
Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z (2011). “Apoptosis and beyond: cytometry in studies of programmed cell death”. Recent Advances in Cytometry, Part B – Advances in Applications. Methods in Cell Biology. 103. pp. 55–98. doi:10.1016/B978-0-12-385493-3.00004-8. ISBN978-0-12-385493-3. PMC3263828. PMID21722800
Li, Peng; Nijhawan, Deepak; Budihardjo, Imawati; Srinivasula, Srinivasa M; Ahmad, Manzoor; Alnemri, Emad S; Wang, Xiaodong (November 1997). “Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade” (English). Cell91 (4): 479–489. doi:10.1016/S0092-8674(00)80434-1. ISSN0092-8674. PMID9390557.
Venturi, Sebastiano (2014). “Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective”. Human Evolution29 (1–3): 185–205. ISSN0393-9375.